Hawaiian Electric Industries receives preliminary court approval for $100 million derivative settlement

Hawaiian Electric agreed to a proposed $100.0M derivative settlement (≈4% of $2.56B market cap) reached Dec 31, 2025, with $47.75M allocated to settle a related securities class action; insurers will fund the settlement and plaintiffs plan to seek 25% ($25.0M) in attorneys’ fees plus up to $475k in expenses. Final approval hearings are scheduled May 28, 2026 (derivative) and Aug 13, 2026 (securities), with an objection deadline of May 7, 2026; no admission of liability and customary releases are included. The company remains profitable LTM with EPS $0.71 and a P/E of 20.89, has reported a full-year 2025 turnaround from a 2024 loss, and updated U.S. federal tax disclosures for an up-to-$250M ATM equity offering.

Analysis

The insurer-funded settlement materially reduces immediate cash risk for HE shareholders but creates a non-linear contingent exposure: if policy limits or sublimits are exhausted by this and other wildfire-related claims, HE shifts from insurer-funded to balance-sheet-funded liabilities quickly — a single additional large verdict or reserve build could force direct payments or capital raises within 6–18 months. The market is likely underestimating this tail because headline ‘insurer pays’ messaging conceals erosion of coverage and higher future premium expense that would hit OPEX and credit metrics over multi-year horizons.

The company’s ATM capacity is the silent lever here: a full $250m issuance equals ~16.9m new shares on our back-of-envelope (2.56bn/14.81 ≈ 172.9m shares outstanding; 16.9m ≈ +9.8% dilution), which would knock EPS down from $0.71 to roughly $0.65 (~8.7% dilution) if proceeds aren’t accretive. That magnitude changes valuation math for a utility trading near a 21x P/E — modest dilution plus persistent margin pressure from higher insurance costs could compress multiple by several points over 12 months.

Competitive dynamics: utilities with concentrated wildfire exposure will trade at an insurance- and capital-cost premium versus diversified regulated peers; this can favor larger, investment-grade utilities for buy-and-hold capital and penalize small regional players trying to fund green transitions via equity. The second-order effect is slower renewables procurement in HE’s territory if capital is diverted to litigation buffers, which could delay state clean-energy targets and temporarily benefit third-party developers holding cash-rich balance sheets.

Catalysts and timing to watch are (1) objector filings by May 7 and derivative final approval May 28, (2) Northern District of California final approval Aug 13, (3) any insurer reserve disclosures in Q2 earnings, and (4) ATM activation windows—each event can move shares 10–25% intraday depending on perceived policy exhaustion or dilution risk.

Key Decisions for Investors

• Buy HE common stock (ticker: HE) up to a 2–3% portfolio weight at <$15.00. Timeframe: 6–12 months. Rationale: limited near-term cash hit if settlement finalizes; target +25% upside if approvals pass and ATM issuance is limited. Risk control: hard stop at -20% (or buy $13 May puts as hedge around the May 28 hearing).
• Event hedge: Buy HE May 2026 $13 puts (or nearest strike) ahead of the May 28 derivative final approval to cap downside into the hearing. Timeframe: 1 month. Risk/reward: small premium (cost) to limit tail loss from a rejected settlement or surprise insurer denial; max loss = premium paid, implied protection ~15–20% downside.
• Conditional leveraged play: If May 28 and Aug 13 approvals occur with no insurer-reserve shock, initiate a Jan 2027 call spread (buy HE Jan 2027 $15 calls / sell $22.50 calls) sized to 1% portfolio risk. Timeframe: 8–12 months. R/R: limited downside = premium paid; upside levered to ~50–100% if sentiment normalizes and ATM remains unused.
• Avoid funding-risk exposure: Do not buy HE ahead of any announced ATM blocks >$50m without re-pricing — if HE activates >$100m of the ATM within 60 days, reduce position by half. Rationale: each $100m equity issuance materially dilutes EPS and resets valuation; treat ATM activation as a negative catalyst until proceeds use is explicit.